PL2413934T3 - Domperidon w niskiej dziennej dawce do zastosowania do leczenia lub profilaktyki choroby związanej z modyfikacją odpowiedzi immunologicznej - Google Patents

Domperidon w niskiej dziennej dawce do zastosowania do leczenia lub profilaktyki choroby związanej z modyfikacją odpowiedzi immunologicznej

Info

Publication number
PL2413934T3
PL2413934T3 PL10711405T PL10711405T PL2413934T3 PL 2413934 T3 PL2413934 T3 PL 2413934T3 PL 10711405 T PL10711405 T PL 10711405T PL 10711405 T PL10711405 T PL 10711405T PL 2413934 T3 PL2413934 T3 PL 2413934T3
Authority
PL
Poland
Prior art keywords
domperidone
alteration
prevention
treatment
immune response
Prior art date
Application number
PL10711405T
Other languages
English (en)
Inventor
Elias David Sabate
Beguer Josep M Homedes
Ochoa Pablo Gómez
Original Assignee
Ecuphar N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecuphar N V filed Critical Ecuphar N V
Publication of PL2413934T3 publication Critical patent/PL2413934T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL10711405T 2009-03-31 2010-03-30 Domperidon w niskiej dziennej dawce do zastosowania do leczenia lub profilaktyki choroby związanej z modyfikacją odpowiedzi immunologicznej PL2413934T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09382040A EP2241317A1 (en) 2009-03-31 2009-03-31 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
PCT/EP2010/054177 WO2010112497A1 (en) 2009-03-31 2010-03-30 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
EP10711405.0A EP2413934B1 (en) 2009-03-31 2010-03-30 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response

Publications (1)

Publication Number Publication Date
PL2413934T3 true PL2413934T3 (pl) 2016-05-31

Family

ID=40801995

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10711405T PL2413934T3 (pl) 2009-03-31 2010-03-30 Domperidon w niskiej dziennej dawce do zastosowania do leczenia lub profilaktyki choroby związanej z modyfikacją odpowiedzi immunologicznej

Country Status (9)

Country Link
US (1) US8802691B2 (pl)
EP (2) EP2241317A1 (pl)
AR (1) AR076016A1 (pl)
DK (1) DK2413934T3 (pl)
ES (2) ES2559762T3 (pl)
HU (1) HUE027348T2 (pl)
PL (1) PL2413934T3 (pl)
PT (1) PT2413934E (pl)
WO (1) WO2010112497A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3949965A1 (en) * 2020-08-07 2022-02-09 Consejo Superior de Investigaciones Cientificas Domperidone for use as antiviral agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372818A (en) * 1993-02-01 1994-12-13 Clemson University Method of treating fescue toxicosis with domperidone
US6224895B1 (en) 1996-12-18 2001-05-01 Clemson University Method for promoting ovulation, parturition, and lactation in mammals
US7887817B2 (en) 2002-01-25 2011-02-15 Aeterna Zentaris Gmbh Process for preventing protozoal diseases
ES2246142B1 (es) 2004-06-03 2007-03-16 Consejo Sup. Investig. Cientificas Nueva composicion terapeutica inmunomoduladora.

Also Published As

Publication number Publication date
PT2413934E (pt) 2016-01-25
EP2241317A1 (en) 2010-10-20
ES2559762T3 (es) 2016-02-15
ES2397193B1 (es) 2013-11-26
HUE027348T2 (en) 2016-10-28
ES2397193A2 (es) 2013-03-05
US8802691B2 (en) 2014-08-12
DK2413934T3 (en) 2016-01-25
WO2010112497A1 (en) 2010-10-07
US20120065167A1 (en) 2012-03-15
AR076016A1 (es) 2011-05-11
EP2413934A1 (en) 2012-02-08
ES2397193R1 (es) 2013-03-25
EP2413934B1 (en) 2015-10-21

Similar Documents

Publication Publication Date Title
GB2482092B (en) Patient interface and aspects thereof
GB2494493B (en) Patient interface and aspects thereof
IL216522A0 (en) Oxidation-stabilized tamper-resistant dosage form
IL233822A (en) Use of a compound to prepare a drug to inhibit the expression of 6-il and / or 1-vcam
EP2406765A4 (en) DEVICE FOR ADMINISTERING A MEDICAMENT TO A PATIENT WITH RESTRICTED PATIENT-SIDED ACCESS TO THE MEDICAMENT IN THE CASE OF CONTRAINDICATIONS AND APPLICATION METHOD THEREFOR
IL232251B (en) Pharmaceutical combination for use in the treatment of type 2 diabetes patients
GB0920499D0 (en) Dose counter
PL2448637T3 (pl) Użycie jednego lub połączenia kannabinoidów roślinnych w leczeniu padaczki
EP2412328A4 (en) MEDICAL TREATMENT DEVICE
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
GB201002243D0 (en) Respiratory disease treatment
IL209220A0 (en) Plant extract and its therapeutic use
GB201002224D0 (en) Respiratory disease treatment
GB0915319D0 (en) Combination medicament
PT2413934E (pt) Domperidona a uma dose diária baixa para utilização no tratamento ou prevenção de uma doença associada a uma alteração na resposta imune
AP2788A (en) Simalikalactone E and use thereof as a medicament
GB0811950D0 (en) Disease prevention and treatment
GB0901832D0 (en) Respiratory disease treatment
GB0910944D0 (en) Respiratory disease treatment
GB0901831D0 (en) Respiratory disease treatment
GB0901902D0 (en) Medicament
GB0903318D0 (en) Medicament
GB201018325D0 (en) Treatment for dupuytren's disease
IL200682A (en) A device for introducing drugs
GB0807824D0 (en) Patient specific immune desensitisation